Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Mammary Gland Biology and Neoplasia
Metadata
Title
Do Inflammatory Cells Participate in Mammary Gland Involution?
Authors
Jenifer Monks
F. Jon Geske
Lisa Lehman
Valerie A. Fadok
Publication date
01-04-2002
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Journal of Mammary Gland Biology and Neoplasia / Issue 2/2002
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI
https://doi.org/10.1023/A:1020351919634

Other articles of this Issue 2/2002

Journal of Mammary Gland Biology and Neoplasia 2/2002 Go to the issue

OriginalPaper

Tumor-Associated Macrophages in Breast Cancer

OriginalPaper

T Cell Memory, Anergy and Immunotherapy in Breast Cancer

OriginalPaper

The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression

OriginalPaper

Influence of Breast Cancer on Thymic Function in Mice

Preface

Preface

OriginalPaper

MUC1 and the Immunobiology of Cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits